최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한중풍·순환신경학회지 = The journal of the society of stroke on korean medicine, v.20 no.1, 2019년, pp.53 - 64
김하리 (경희대학교 대학원 한방순환신경내과학교실) , 정혜선 (경희대학교 대학원 한방순환신경내과학교실) , 최정우 (경희대학교 대학원 한방순환신경내과학교실) , 신희연 (경희대학교 대학원 한방순환신경내과학교실) , 조승연 (경희대학교 대학원 한방순환신경내과학교실) , 박성욱 (경희대학교 대학원 한방순환신경내과학교실) , 고창남 (경희대학교 대학원 한방순환신경내과학교실) , 박정미 (경희대학교 대학원 한방순환신경내과학교실)
■ Objectives The purpose of this case is to report the effectiveness of Korean medicine in the treatment of irritable bowel syndrome with diarrhea. ■ Methods The patient was diagnosed as a Soeumin, one of the 4 constitution types in Korean medicine, and treated with herbal medicine, Os...
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-91.
Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clinical Epidemiology. 2014;6:71-80.
Lee SY, Lee KJ, Kim SJ, et al. Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study. Digestion. 2009;79:196-201.
El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Alimentary Pharmacology Therapeutics. 2002;16:1171-85.
Choi MG. Diagnosis and Management of Chronic Diarrhea. The Korean Journal of Medicine. 2012;83(5):585-90.
Svedlund J, Sjodin I, Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive Diseases and Sciences. 1988;33(2):129-34.
Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scandinavian Journal of Gastroenterology. 2003;38(9):947-54.
Schiffmann R, Bichet DG, Jovanovic A, Hughes DA, Giugliani R, Feldt-Rasmussen U, et al. Migalastat improves diarrhea in patients with Fabry disease: clinical-bio-marker correlations from the phase 3 FACETS trial. Orphanet journal of rare diseases. 2018;13(68):1-7.
Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of Life in Persons with Irritable Bowel Syndrome Development and Validation of a New Measure. Digestive Diseases and Sciences. 1988;43(2):400-11.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262-79.
Kim HJ, Cha RR, Kim HJ. Understanding the Rome IV: Irritable Bowel Syndrome and Functional Diarrhea. The Korean Journal of Medicine. 2017;92(4):366-71.
Kim JH, Lee SR. Irritable Bowel Syndrome. The Korean Journal of Gastroenterology. 2019;73(2):84-91.
Spiegel B, Bolus R, Harris LA, Lucak S, Naliboff S, Esrailian E, et al. Measuring IBS patient reported outcomes with an abdominal pain numeric rating scale: results from the proof cohort. Alimentary Pharmacology Therapeutics. 2009;30(11-12):1159-70.
Drossman DA, Wong RK. Quality of life measures in irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology. 2010;4(3);277-84.
Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, et al. Characterization of Health Related Quality of Life (HRQOL) for Patients With Functional Bowel Disorder (FBD) and Its Response to Treatment. American Journal of Gastroenterology. 2007;102:1442-53.
Lee YW, Yoo HS, Cho CK. Analysis of Case Reports for Korean medical treatment of Irritable Bowel Syndrome. Journal of Haehwa Medicine. 2016;25(1):87-97.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.